Cargando…

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments

TP53 mutation is one of the most frequent genetic alterations in head and neck squamous cell carcinoma (HNSCC) and results in an accumulation of p53 protein in tumor cells. This makes p53 an attractive target to improve HNSCC therapy by restoring the tumor suppressor activity of this protein. Therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Bakker, Tycho, Journe, Fabrice, Descamps, Géraldine, Saussez, Sven, Dragan, Tatiana, Ghanem, Ghanem, Krayem, Mohammad, Van Gestel, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770810/ https://www.ncbi.nlm.nih.gov/pubmed/35071005 http://dx.doi.org/10.3389/fonc.2021.799993

Ejemplares similares

Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas
por: Kindt, Nadège, et al.
Publicado: (2017)

PRIMA-1 and PRIMA-1(Met) (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies
por: Perdrix, Anne, et al.
Publicado: (2017)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
por: Lechien, Jérôme R., et al.
Publicado: (2020)

Dealing with Macrophage Plasticity to Address Therapeutic Challenges in Head and Neck Cancers
por: Furgiuele, Sonia, et al.
Publicado: (2022)

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma
por: Krayem, Mohammad, et al.
Publicado: (2019)

Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma
por: Kindt, Nadège, et al.
Publicado: (2019)

High infiltration of CD68+ macrophages is associated with poor prognoses of head and neck squamous cell carcinoma patients and is influenced by human papillomavirus
por: Seminerio, Imelda, et al.
Publicado: (2018)

Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms
por: Soumoy, Laura, et al.
Publicado: (2020)

ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection
por: Descamps, Géraldine, et al.
Publicado: (2020)

Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients
por: Furgiuele, Sonia, et al.
Publicado: (2022)

Infiltration of FoxP3+ Regulatory T Cells is a Strong and Independent Prognostic Factor in Head and Neck Squamous Cell Carcinoma
por: Seminerio, Imelda, et al.
Publicado: (2019)

Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research
por: Cogels, Morgane M., et al.
Publicado: (2021)

Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas
por: Kindt, Nadège, et al.
Publicado: (2021)

Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
por: Soumoy, Laura, et al.
Publicado: (2019)

Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis
por: Soumoy, Laura, et al.
Publicado: (2020)

Macrophage Profiling in Head and Neck Cancer to Improve Patient Prognosis and Assessment of Cancer Cell–Macrophage Interactions Using Three-Dimensional Coculture Models
por: Mhaidly, Nour, et al.
Publicado: (2023)

Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients
por: Descamps, Géraldine, et al.
Publicado: (2016)

The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma
por: Sabbah, Malak, et al.
Publicado: (2023)

Editorial: Advances in the Involvement of Human Papilloma Virus in Head and Neck Squamous Cell Carcinoma
por: Lechien, Jerome R., et al.
Publicado: (2022)

Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value
por: Najem, Ahmad, et al.
Publicado: (2021)

Proteomic Study of HPV-Positive Head and Neck Cancers: Preliminary Results
por: Descamps, Géraldine, et al.
Publicado: (2014)

Immune Cell Density Evaluation Improves the Prognostic Values of Staging and p16 in Oropharyngeal Cancer
por: Descamps, Géraldine, et al.
Publicado: (2022)

RTK Inhibitors in Melanoma: From Bench to Bedside
por: Sabbah, Malak, et al.
Publicado: (2021)

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma
por: Krayem, Mohammad, et al.
Publicado: (2018)

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma
por: Najem, Ahmad, et al.
Publicado: (2022)

Editorial: Quality Assessment Across Disciplines in Head and Neck Cancer Treatment
por: Vermorken, Jan B., et al.
Publicado: (2021)

Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies
por: Najem, Ahmad, et al.
Publicado: (2023)

Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review
por: Lechien, Jerome R., et al.
Publicado: (2019)

Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas
por: Idel, Christian, et al.
Publicado: (2021)

Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity
por: Szturz, Petr, et al.
Publicado: (2020)

Restoration of the Oral Microbiota After Surgery for Head and Neck Squamous Cell Carcinoma Is Associated With Patient Outcomes
por: Chan, Jason Y. K., et al.
Publicado: (2021)

Analysis of Adenoviral p53 Gene Therapy Clinical Trials in Recurrent Head and Neck Squamous Cell Carcinoma
por: Sobol, Robert E., et al.
Publicado: (2021)

Exosomes in Head and Neck Squamous Cell Carcinoma
por: Xiao, Cheng, et al.
Publicado: (2019)

Preventive and Therapeutic Effect of Metformin in Head and Neck Cancer: A Concise Review
por: Bouland, Cyril, et al.
Publicado: (2023)

Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical Progresses
por: Laetitia, Gheysen, et al.
Publicado: (2020)

Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck
por: Szturz, Petr, et al.
Publicado: (2016)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance
por: Kehagias, Pashalina, et al.
Publicado: (2022)

Cytokine Landscape in Central Nervous System Metastases
por: Marin, Julie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6mv9gnnl92jcpgahg1mgbj6tm5